People with eczema can bathe as often as they want, government-funded, study finds Researchers found that the frequency in which participants washed had no correlation with increased skin dryness.…
Oral insulin found to delay onset of type 1 diabetes in children Researchers found that the progression to type 1 diabetes mellitus was around 50% slower in infants genetically at risk of the disease who received oral insulin for three years compared to the placebo group.…
Focus on early stages of supply chain to address medicines shortages, study finds Researchers said that other contributing factors to global supply issues were poor forecasting based on “outdated” prescription data and procurement policies.…
Promoting public trust in pharmaceutical health systems is ‘critical’ The Journal of Pharmaceutical Health Services Research’s new themed collection highlights the latest research on improving transparency and accountability in pharmaceutical and health systems.…
‘Cocktail’ of medicines in waterways could pose new AMR threat Research has revealed that medicines combined with ciprofloxacin are more likely to increase antibiotic-resistant genes compared with exposure to antibiotics alone.…
Health news round-up: clinical research and interdisciplinary working Senior clinical reporter Joanna Robertson summarises some important developments in health news.…
RPS appoints new chief scientist Amira Guirguis, who chairs the RPS science and research committee, will begin her role on a phased basis from 13 October 2025.…
Time to approve UK clinical trials has more than halved, says MHRA The Medicines and Healthcare products Regulatory Agency said the introduction of AI methods had contributed to quicker approval times.…
Beyond GLP-1: the next wave of weight-loss medication innovation From agonists and antagonists to ultrasound therapy, an in-depth look at the drug development pipeline has highlighted several promising new potential weight-loss medicines.…
Combination inhaler therapy cuts asthma attacks in children by almost half Study results revealed that the annualised rate of asthma attacks was lower in participants who used a budesonide-formoterol inhaler compared with participants who used a short-acting β2-agonist inhaler.…
